Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru

Descripción del Articulo

Objectives: To describe Bartonella bacilliformis’ infection treatment, in Caraz, Ancash. Design: Observational, transverse and retrospective study. Setting: Caraz, Ancash, Peru. Patients: Five hundred and eighteen patients. Interventions: Study of clinical histories data from January 2004 through Ma...

Descripción completa

Detalles Bibliográficos
Autor: Arroyo, Álvaro
Formato: artículo
Fecha de Publicación:2008
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/1171
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1171
Nivel de acceso:acceso abierto
Materia:Bartonella bacilliformis
agentes antibacterianos.
anti-bacterial agents.
id REVUNMSM_5fffcc1944e8c6d11330ae1d2a024c40
oai_identifier_str oai:ojs.csi.unmsm:article/1171
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
spelling Treatment outlines for non-complicated Carrion´s Disease, in Caraz, PeruEsquemas de tratamiento para la enfermedad de Carrión no complicada en la ciudad de Caraz, PerúArroyo, ÁlvaroBartonella bacilliformisagentes antibacterianos.Bartonella bacilliformisanti-bacterial agents.Objectives: To describe Bartonella bacilliformis’ infection treatment, in Caraz, Ancash. Design: Observational, transverse and retrospective study. Setting: Caraz, Ancash, Peru. Patients: Five hundred and eighteen patients. Interventions: Study of clinical histories data from January 2004 through March 2005 at Caraz Hospital. Main outcome measures: Treatment outlines for Bartonella bacilliformis infection. Results: In the acute phase, 248 patients were registered; in 215 (86,7%) chloramphenicol treatment was indicated but the 50 mg/kg loading dose by 3 days was not prescribed; 164 (66,1%) patients needed a higher chloramphenicol dose of 25 mg/kg. In the eruptive phase, 270 patients were registered; in 260 (96,3%) rifampicin was indicated and 222 (82,2%) for more than the 21 treatment days suggested for this antibiotic. Clinical cure was obtained with chloramphenicol in 89% and 93,1% with rifampicin. Conclusions: In the population studied there was a tendency to increase both chloramphenicol dose and rifampicin number of treatment days respectively in the acute and eruptive phases of Carrion’s disease.Objetivos: Describir el tratamiento para infección por Bartonella bacilliformis, en Caraz, Ancash. Diseño: Estudio observacional, transversal y retrospectivo. Lugar: Caraz, Ancash, Perú. Pacientes: Quinientos dieciocho pacientes. Intervenciones: Recolección de datos, entre enero 2004 y marzo 2005, por medio de historias clínicas realizadas en el Hospital de Caraz. Principales medidas de resultados: Esquemas de tratamiento para infección por Bartonella bacilliformis. Resultados: Se registró 248 pacientes en fase aguda. En 215 (86,7%), se indicó cloramfenicol para su tratamiento y en todos ellos no se registró la dosis de carga de 50 mg/kg, por 3 días; 164 (66,1%) pacientes necesitaron una dosis de cloramfenicol superior a 25 mg/kg. En fase eruptiva, se registró 270 pacientes; en 260 (96,3%) se indicó rifampicina y 222 (82,2%) sobrepasaron los 21 días de duración de tratamiento con dicho antibiótico. Cloramfenicol obtuvo un 89% de eficacia en curación clínica y rifampicina, 93,1%. Conclusiones: En la población estudiada, existió una marcada tendencia a aumentar la dosis de cloramfenicol e incrementar el número de días de tratamiento con rifampicina, en fase aguda y eruptiva, respectivamente, de la Enfermedad de Carrión. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2008-03-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/117110.15381/anales.v69i1.1171Anales de la Facultad de Medicina; Vol. 69 No. 1 (2008); 7-11Anales de la Facultad de Medicina; Vol. 69 Núm. 1 (2008); 7-111609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1171/978Derechos de autor 2008 Álvaro Arroyohttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/11712020-04-14T22:06:07Z
dc.title.none.fl_str_mv Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
Esquemas de tratamiento para la enfermedad de Carrión no complicada en la ciudad de Caraz, Perú
title Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
spellingShingle Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
Arroyo, Álvaro
Bartonella bacilliformis
agentes antibacterianos.
Bartonella bacilliformis
anti-bacterial agents.
title_short Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
title_full Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
title_fullStr Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
title_full_unstemmed Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
title_sort Treatment outlines for non-complicated Carrion´s Disease, in Caraz, Peru
dc.creator.none.fl_str_mv Arroyo, Álvaro
author Arroyo, Álvaro
author_facet Arroyo, Álvaro
author_role author
dc.subject.none.fl_str_mv Bartonella bacilliformis
agentes antibacterianos.
Bartonella bacilliformis
anti-bacterial agents.
topic Bartonella bacilliformis
agentes antibacterianos.
Bartonella bacilliformis
anti-bacterial agents.
description Objectives: To describe Bartonella bacilliformis’ infection treatment, in Caraz, Ancash. Design: Observational, transverse and retrospective study. Setting: Caraz, Ancash, Peru. Patients: Five hundred and eighteen patients. Interventions: Study of clinical histories data from January 2004 through March 2005 at Caraz Hospital. Main outcome measures: Treatment outlines for Bartonella bacilliformis infection. Results: In the acute phase, 248 patients were registered; in 215 (86,7%) chloramphenicol treatment was indicated but the 50 mg/kg loading dose by 3 days was not prescribed; 164 (66,1%) patients needed a higher chloramphenicol dose of 25 mg/kg. In the eruptive phase, 270 patients were registered; in 260 (96,3%) rifampicin was indicated and 222 (82,2%) for more than the 21 treatment days suggested for this antibiotic. Clinical cure was obtained with chloramphenicol in 89% and 93,1% with rifampicin. Conclusions: In the population studied there was a tendency to increase both chloramphenicol dose and rifampicin number of treatment days respectively in the acute and eruptive phases of Carrion’s disease.
publishDate 2008
dc.date.none.fl_str_mv 2008-03-17
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1171
10.15381/anales.v69i1.1171
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1171
identifier_str_mv 10.15381/anales.v69i1.1171
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1171/978
dc.rights.none.fl_str_mv Derechos de autor 2008 Álvaro Arroyo
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2008 Álvaro Arroyo
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 69 No. 1 (2008); 7-11
Anales de la Facultad de Medicina; Vol. 69 Núm. 1 (2008); 7-11
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238241340751872
score 13.936249
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).